COOPER COMPANIES, INC. News
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
see moreCOOPER COMPANIES, INC. Market News
3d
CooperCompanies (COO): Q2 Call Sets Stock Focus Up
- CooperCompanies (COO) announced its Q2 2026 earnings webcast for June 4, 2026. With no other material news in the last week, investors are focused on segment organic growth, margin trends, and capital allocation after a strong Q1 that raised guidance. This article summarizes the latest facts, what to watch on the call, and practical investor takeaways.
10d
CooperCompanies: ESG Push, Guidance Lift Plus Debt
CooperCompanies (COO) moved the needle this week with a high-profile sustainability initiative from CooperVision, continued strong fiscal guidance from Q1, and meaningful financing flexibility after a recent term-loan amendment. These concrete developments — not speculation — shape near-term investor expectations for the vision-care and women’s health leader.
17d
COO: Q1 Beat and Japan MiSight Launch
CooperCompanies reported a solid Q1 FY2026 with revenue growth, stronger EPS, meaningful free cash flow and a $92.5M buyback. Strategic wins — notably the rollout of MiSight® 1 day in Japan and the MADE BETTER™ sustainability initiative — reinforce CooperVision’s premium push and support CooperCompanies’ upgraded FY2026 guidance.
24d
CooperCompanies Q1 Upside, Activists Demand Split!
CooperCompanies reported solid Q1 results and a large share-repurchase while activists press for a split of CooperVision and CooperSurgical. Operational strain at CooperSurgical, including a sharp drop in operating income and IT-control weaknesses, keeps strategic change and governance front-and-center for investors.
06 Apr at 04:21
COO Q1 Beat: Guidance Raised, Buybacks Accelerate.
CooperCompanies reported a solid Q1 with revenue of $1.024B, stronger margins and an upwardly revised FY26 guidance. With $92.5M in share repurchases and improved operating leverage, the stock reaction hinges on execution in CooperVision and CooperSurgical ahead.
30 Mar at 04:21
CooperCompanies: Vision Sales Lift COO Share Rally
CooperCompanies (COO) saw a roughly 5% stock uptick after stronger-than-expected contact-lens sales, while a recent term-loan amendment extends debt maturities and expands borrowing flexibility. Together, these developments strengthen near-term cash-flow outlook and strategic optionality for the company.
23 Mar at 04:21
COO Stock Surges on Q1 Beat, MiSight Uptake Gains!
CooperCompanies (COO) reported a strong fiscal Q1 2026 with a revenue beat, raised guidance, accelerating CooperVision growth driven by MyDay and MiSight, and disciplined cash deployment including buybacks and debt reduction—providing clear, near-term catalysts for the stock.